KOSDAQ · 397030 · Biotech & Pharma · ₩397030

AprilBio에이프릴바이오

397030 · KOSDAQ · ₩397030 · 에이프릴바이오

₩12,400▲ ₩60 (0.49%)End-of-day · Oct 28, 2026 · End-of-day prices.

Trade

Sell Buy

Filings

Amended: Change of largest shareholder[기재정정]최대주주변경을수반하는주식담보제공계약체결
Predicted impact: Low
Oct 23, 2026Open on DART
5%+ holding report주식등의대량보유상황보고서(일반)
Predicted impact: Low
Oct 23, 2026Open on DART
Investor relations (IR) event기업설명회(IR)개최Oct 7, 2026Open on DART
5%+ holding report주식등의대량보유상황보고서(일반)Sep 28, 2026Open on DART
Results of Extraordinary Shareholders' Meeting임시주주총회결과Sep 22, 2026Open on DART
Notice on Grant of Stock Purchase Options주식매수선택권부여에관한신고Sep 22, 2026Open on DART
Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Sep 22, 2026Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Sep 18, 2026Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Sep 17, 2026Open on DART
5%+ holding report주식등의대량보유상황보고서(약식)Sep 9, 2026Open on DART
Amended: Shareholders' meeting called[기재정정]주주총회소집결의 (임시주주총회)Sep 7, 2026Open on DART
Notice of shareholders' meeting주주총회소집공고Sep 7, 2026Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 28, 2026Open on DART
5%+ holding report주식등의대량보유상황보고서(일반)Aug 26, 2026Open on DART
Major management matter relevant to investors투자판단관련주요경영사항 (MCB 물질이전 계약 체결 건)Aug 21, 2026Open on DART
Amended: Change of largest shareholder[기재정정]최대주주변경Aug 19, 2026Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 19, 2026Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 19, 2026Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 19, 2026Open on DART
Half-year report (Jun 2026)반기보고서 (2026.06)Aug 13, 2026Open on DART
Shareholders' meeting called주주총회소집결의 (임시주주총회)Aug 11, 2026Open on DART
Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Aug 11, 2026Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 29, 2026Open on DART
Change of largest shareholder최대주주변경을수반하는주식담보제공계약체결Jul 24, 2026Open on DART
Change of largest shareholder최대주주변경Jul 24, 2026Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 24, 2026Open on DART
5%+ holding report주식등의대량보유상황보고서(일반)Jul 24, 2026Open on DART
Securities Issuance Results (Voluntary Disclosure) (Third-Party Allotment – Non-Voting Convertible Preferred Shares)증권발행결과(자율공시) (제3자배정-무의결권부전환우선주)Jul 23, 2026Open on DART
Securities Issuance Results (Voluntary Disclosure) (Third-Party Allotment)증권발행결과(자율공시) (제3자배정)Jul 23, 2026Open on DART
Securities Issuance Results (Voluntary Disclosure) (Third-Party Allotment Rights Offering – Voting Convertible Preferred Shares)증권발행결과(자율공시) (제3자배정 유상증자-의결권부전환우선주)Jul 23, 2026Open on DART
[Corrected Filing] Conclusion of Agreement on Change in Management Control[기재정정]경영권변경등에관한계약체결Jul 23, 2026Open on DART
Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Jul 23, 2026Open on DART
Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Jul 23, 2026Open on DART
Major management matter relevant to investors투자판단관련주요경영사항 (기술도입 계약 체결)Jul 21, 2026Open on DART
5%+ holding report주식등의대량보유상황보고서(일반)Jul 1, 2026Open on DART
[Corrected Filing] Conclusion of Agreement on Change in Management Control[기재정정]경영권변경등에관한계약체결Jun 25, 2026Open on DART
Exchange inquiry about a news report or price move조회공시요구(풍문또는보도)에대한답변(부인)Jun 25, 2026Open on DART
Entry into Agreement on Change of Management Control경영권변경등에관한계약체결Jun 25, 2026Open on DART
Rights offering (paid-in capital increase) decision주요사항보고서(유상증자결정)Jun 25, 2026Open on DART
Rights offering (paid-in capital increase) decision주요사항보고서(유상증자결정)Jun 25, 2026Open on DART
Rights offering (paid-in capital increase) decision주요사항보고서(유상증자결정)Jun 25, 2026Open on DART
Exchange inquiry about a news report or price move조회공시요구(풍문또는보도)Jun 24, 2026Open on DART
5%+ holding report주식등의대량보유상황보고서(약식)Jun 10, 2026Open on DART
Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
Major management matter relevant to investors투자판단관련주요경영사항 (유한양행, SAFA 기반 융합단백질 기술라이선스 및 공동연구개발 계약 조기 종료)May 4, 2026Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 16, 2026Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 16, 2026Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 16, 2026Open on DART
5%+ holding report주식등의대량보유상황보고서(약식)Apr 9, 2026Open on DART
Annual general meeting results정기주주총회결과Mar 25, 2026Open on DART

Titles in Korean until English translations are added.

Also known as: AprilBio / 에이프릴바이오 / 397030 / KRX:397030

Source: KRX statistical information